-
AZD1480 for Reliable JAK2/STAT3 Assays
2026-08-16
This scenario-based guide explains how AZD1480 (SKU A4137) can support better-controlled viability, proliferation, cytotoxicity, and pathway assays. It connects formulation, concentration design, combination studies, and STAT3 readouts with current evidence on tumor-intrinsic IL-6–JAK2–STAT3 signaling.
-
GPER1 as a Chemoprevention Target in Prostate Cancer
2026-08-15
The reference study identifies GPER1 as a stage-sensitive protective factor during the transition from high-grade prostatic intraepithelial neoplasia to prostate cancer. Using human samples, public datasets, TRAMP mice, pharmacological intervention, and mechanistic cell assays, the authors show that GPER1 activation suppresses tumor progression and epithelial-to-mesenchymal transition.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-14
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides a fluorescent detection step for rabbit IgG primary antibodies in immunofluorescence, IHC, ICC, and selected flow cytometry workflows. It should be used as a research reagent with assay-specific titration and controls, not as a diagnostic reagent or an automatically validated live-cell stain.
-
Bradykinin Assays: From Vascular Signal to Mechanism
2026-08-14
Bradykinin assays can reveal how endothelial signaling becomes vascular permeability, smooth muscle contraction, pain, or inflammation. This guide presents a mechanism-first design strategy, using orthogonal validation lessons from a 2025 mitochondrial study to improve interpretation of Bradykinin research.
-
0.4% Trypan Blue Solution: Practical Cell Viability
2026-08-13
0.4% Trypan Blue Solution supports rapid cell viability measurement, live/dead cell discrimination, and cell counting by staining cells with compromised membranes. It is intended for research workflows such as cell culture and cytotoxicity assays, not for diagnostic, clinical, or medical use.
-
NLRP3 Astrocyte Remodeling in Morphine Tolerance
2026-08-13
Yuan et al. identify NLRP3 inflammasome activation as a contributor to morphine tolerance and connect it with a shift in spinal astrocyte markers toward the neurotoxic A1 phenotype. Their MCC950 intervention study links reduced NLRP3 signaling with delayed tolerance and partial restoration of A2-associated S100A10, providing a pharmacological framework for studying neuroinflammation in opioid adaptation.
-
From Membrane Damage to Translational Evidence
2026-08-12
A thought-leadership guide to using dual-fluorescence viability staining to connect nanomaterial-driven bacterial membrane damage with stronger translational evidence in osteomyelitis research.
-
mCherry mRNA for Redox Biosensor Assays
2026-08-12
Learn how mCherry mRNA can separate reporter delivery and translation effects from genuine redox-biosensor biology. This article explains how EZ Cap™ mCherry mRNA (5mCTP, ψUTP) supports rigorous assay controls while clarifying the limits of applying a bacterial NADH/NAD+ study to other cell systems.
-
Gap19: Selective Connexin 43 Hemichannel Blocker
2026-08-11
Gap19 enables targeted interrogation of Cx43 hemichannels while preserving gap junction channel function, making it useful for astrocyte ATP-release assays, ischemic brain studies, and inflammation research. This guide connects product specifications with reproducible workflows, selectivity controls, and troubleshooting decisions.
-
GPER1 as a Chemoprevention Target in Prostate Cancer
2026-08-11
The reference study identifies GPER1 as a stage-dependent protective factor in prostate cancer, combining human data, public datasets, TRAMP mice, and cell-based mechanistic experiments. Its central finding is that GPER1 activation with G1 can block progression from high-grade prostatic intraepithelial neoplasia to carcinoma, supporting further evaluation of GPER1-directed chemoprevention.
-
0.4% Trypan Blue Solution: Practical Guide
2026-08-10
0.4% Trypan Blue Solution supports exclusion-based cell viability measurement, cell counting, and broad live/dead cell discrimination by staining cells with compromised membranes blue. It is intended for research workflows such as culture checks and cytotoxicity assays, not for diagnostic, clinical, or medical use.
-
AO/PI Double Staining Kit: Reliable Viability
2026-08-09
Learn how the AO/PI Double Staining Kit, SKU K2238, addresses common problems in cell viability, apoptosis detection, and necrosis detection workflows. This scenario-based guide connects Acridine Orange Propidium Iodide staining with practical controls, storage, interpretation, and evidence from melanoma research.
-
AO/PI Double Staining Kit: Practical Guide
2026-08-08
The AO/PI Double Staining Kit provides a rapid fluorescent cell staining workflow for separating viable, apoptotic, and necrotic cell populations by green, orange, and red fluorescence. It is suitable for research cell viability and cell death screening, but it should not be treated as a standalone method for clinical validation, pathway assignment, or quantitative biomarker confirmation.
-
SU 5402 Workflows for RTK Signaling Studies
2026-08-07
SU 5402 enables mechanism-focused interrogation of VEGFR2, FGFR, and PDGFR signaling across oncology assays and carefully bounded neuronal experiments. This guide translates its biochemical profile into practical dose-setting, phospho-protein, apoptosis, and cell-cycle workflows while separating established evidence from exploratory HSV-1 applications.
-
Neticonazole Hydrochloride: Dual-Action Imidazole Antifungal
2026-08-07
Neticonazole Hydrochloride bridges antifungal and oncological research with validated action in both cutaneous candidiasis and colorectal cancer models. This guide details practical workflows, protocol parameters, and troubleshooting tips for maximizing its dual utility, highlighting insights from advanced nanotherapeutic delivery studies.